Mouse Monoclonal C-Myc/MYC antibody. Suitable for IHC-P and reacts with Human samples. Cited in 11 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human MYC.
View Alternative Names
BHLHE39, MYC, Myc proto-oncogene protein, Class E basic helix-loop-helix protein 39, Proto-oncogene c-Myc, Transcription factor p64, bHLHe39
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-c-Myc antibody [8] (AB17355)
Immunohistochemistry of kidney tissue using ab17355 at 10 μg/ml.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
C-Myc is involved in regulating cell growth and proliferation. It forms part of the Myc/Max complex which binds to DNA to regulate gene expression. This activity affects cellular metabolism ribosome biogenesis and cell cycle entry emphasizing its regulation of cellular energy and stress response. Its expression levels critically govern normal cellular functions and homeostasis.
Pathways
C-Myc plays an important role in the cell cycle pathway and apoptosis regulation. Specifically c-Myc is associated with the Wnt signaling pathway which influences cellular proliferation and differentiation. It also interacts with other proteins like Cyclin D1 influencing cell cycle control. These interactions ensure c-Myc's involvement in regulating key processes related to cell proliferation and stability.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
British journal of haematology 204:1307-1324 PubMed38462771
2024
Applications
Unspecified application
Species
Unspecified reactive species
British journal of haematology 202:550-565 PubMed37226519
2023
Applications
Unspecified application
Species
Unspecified reactive species
Disease markers 2022:9087190 PubMed35450028
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports : PubMed33432363
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 11:541 PubMed32425787
2020
Applications
Unspecified application
Species
Unspecified reactive species
Epigenetics 14:1125-1140 PubMed31216925
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 74:651-663.e8 PubMed30954402
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the American Heart Association 8:e009871 PubMed30563421
2018
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 36:5852-5860 PubMed28628118
2017
Applications
IP
Species
Unspecified reactive species
Methods in molecular biology (Clifton, N.J.) 1012:117-33 PubMed24006062
2013
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com